Effect of Sulforaphane in Broccoli Sprouts on Nrf2 Activation

NCT01315665 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2019-02-15

Study results available
· View outcomes & findings →

Summary

The purpose of this study to investigate the effect of sulforaphane from macerated broccoli sprouts in humans and to evaluate less invasive methods of assessing potential anti-inflammatory drugs in CF.

Conditions

Interventions

DIETARY_SUPPLEMENT

Broccoli sprouts

Subjects (both healthy volunteers and subjects with cystic fibrosis) will consume 100 gm of raw broccoli sprouts once daily for 5 consecutive days.

Sponsors & Collaborators

  • Cystic Fibrosis Foundation

    collaborator OTHER
  • University Hospitals Cleveland Medical Center

    lead OTHER

Principal Investigators

  • James F. Chmiel, MD, MPH · Rainbow Babies and Children's Hospital

Study Design

Allocation
NON_RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
49 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2011-04-30
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01315665 on ClinicalTrials.gov